David Dao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
David Dao has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Dimitra Skondra
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL, United States
1 shared publication - John Moir
Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA
1 shared publication - Lincoln T. Shaw
Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA
1 shared publication - Rahul Komati
Retina Consultants Ltd. (M.P.B., M.S., R.K., K.W.P.), Des Plaines, Illinois, USA
1 shared publication - Saira Khanna
Department of Ophthalmology and Visual Science, University of Chicago Medical Center, Chicago, IL 60637, USA
1 shared publication - Seenu M. Hariprasad
Department of Ophthalmology and Visual Science, University of Chicago, Chicago, IL 60637, USA
1 shared publication
Latest Publications
- Open Access
- 16 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7849
Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguish atypical MacTel from other macular conditions with similar presentations. We performed a retrospective review of patients referred to our academic retinal practice with unconfirmed or misdiagnosed MacTel between July 2017 and July 2021. Patients’ OCTA imaging findings were reviewed to guide the appropriate diagnosis and management of atypical MacTel. Fifteen eyes from eight patients were included in this study. Six patients were referred with previous diagnoses of either full-thickness macular hole, lamellar hole, vitreomacular traction (VMT), postoperative cystoid macular edema (CME), or diabetic macular edema (DME). Two patients were referred to us to confirm the diagnosis of MacTel. OCTA revealed telangiectatic vessels in the temporal parafovea of all 15 eyes. OCTA also highlighted previously undiagnosed subretinal neovascularization (SRNV) in seven eyes. OCTA imaging is a valuable imaging modality to distinguish MacTel from other macular conditions, whose treatment courses vary substantially. Due to its ease of use, it holds immense potential in the future as treatments for non-proliferative MacTel emerge.
- 16 July 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (14) , 7849
Open AccessUse of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
Macular telangiectasia Type 2 (MacTel) is a bilateral acquired retinal disease characterized by both vascular changes and atrophy of the retina. The purpose of this case series is to highlight the use of optical coherence tomography angiography (OCTA) as a non-invasive imaging modality to distinguish atypical MacTel from other macular conditions with similar presentations. We performed a retrospective review of patients referred to our academic retinal practice with unconfirmed or misdiagnosed MacTel between July 2017 and July 2021. Patients’ OCTA imaging findings were reviewed to guide the appropriate diagnosis and management of atypical MacTel. Fifteen eyes from eight patients were included in this study. Six patients were referred with previous diagnoses of either full-thickness macular hole, lamellar hole, vitreomacular traction (VMT), postoperative cystoid macular edema (CME), or diabetic macular edema (DME). Two patients were referred to us to confirm the diagnosis of MacTel. OCTA revealed telangiectatic vessels in the temporal parafovea of all 15 eyes. OCTA also highlighted previously undiagnosed subretinal neovascularization (SRNV) in seven eyes. OCTA imaging is a valuable imaging modality to distinguish MacTel from other macular conditions, whose treatment courses vary substantially. Due to its ease of use, it holds immense potential in the future as treatments for non-proliferative MacTel emerge.